Press release
Cancer Profiling Market Progress & Manufacturer Contribution Highlighted until 2028 | Key Players - Agendia, Genomic Health , Oxford Gene Technology , NeoGenomics Laboratories, RiboMed Biotechnologies , BioTheranostics, Proteome Sciences PLC
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=358
Next-generation sequencing in the cancer profiling is helping in identifying multiple tumor mutations. Many cancer centers have already adopted next-gen sequencing-based genetic profiling using target gene capturing. Oncologists across the world are using cancer profiling method along with the rise in adoption of cancer biomarkers for tumor profiling. Moreover, factors including point-of-care diagnostic test, and rising demand for personalized medicine is offering opportunities for leading companies in the cancer profiling market.
As per the research report compiled by Fact.MR, the global cancer profiling market is expected to witness strong growth, registering 17.7% CAGR during the forecast period 2017-2026. By the end of 2026, the global cancer profiling market is estimated to reach US$ 122,129.6 million revenue. Increasing incidences of new cases of cancer are resulting in the rising use of cancer profiling. As per National Cancer Institute, new cancer cases are likely to reach 22 million within next two years. Moreover, increasing adoption of precision medicine treatment is also driving the demand for cancer profiling. Below are the few insights on how the global cancer profiling market will perform in the coming years.
Read Detailed Index of full Research Study at @ https://www.factmr.com/report/358/cancer-profiling-market
Forecast Highlights on Global Cancer Profiling Market
North America is expected to remain dominant in the global cancer profiling market during the forecast period 2017-2026. Changing lifestyle with increasing consumption of alcohol, smoking is leading to the increasing number of people suffering from cancer. Moreover, increasing investment in research and development activities are driving the demand for cancer profiling in the region.
Asia Pacific Excluding Japan (APEJ) and Europe are also witnessing significant growth in the cancer profiling. Increasing incidence of lung cancer and prostate cancer in central, eastern, and southern Europe is driving the demand for cancer profiling. Meanwhile, breast cancer is the most diagnosed cancer among women in China and India.
Next-generation sequencing is expected to be the highly-preferred technique in cancer profiling market. By the end of 2026, next-generation sequencing is estimated to reach 62,000 million revenue.
Pharmaceutical and biotech companies are expected to be the largest users of cancer profiling. Pharmaceutical and biotech companies are estimated to surpass US$ 52,400 million revenue by the end of 2026.
Diagnosis is expected to witness significant growth in the global cancer profiling market. By the end of 2026, diagnosis is estimated to surpass US$ 40,000 million in terms of revenue.
The report has also profiled leading players in the global market for cancer profiling, which will remain active through 2026. These include companies such as Roche Holdings, Caris Life Sciences, GenScript, Illumina, Inc. (U.S.), Proteome Sciences PLC, BioTheranostics, NeoGenomics Laboratories, RiboMed Biotechnologies Inc., Genomic Health Inc., Oxford Gene Technology Ltd., and Agendia.
Ask Industry Expert about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=358
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Profiling Market Progress & Manufacturer Contribution Highlighted until 2028 | Key Players - Agendia, Genomic Health , Oxford Gene Technology , NeoGenomics Laboratories, RiboMed Biotechnologies , BioTheranostics, Proteome Sciences PLC here
News-ID: 1788670 • Views: …
More Releases from Fact.MR
Maleic Anhydride Market: Anticipated Growth to US$ 4.1 Billion | Fact.MR
A recent Fact.MR analysis projects that the global market for Maleic Anhydride will expand at a compound annual growth rate (CAGR) of 3.4% between 2022 and 2032. The industry is predicted to produce a dollar opportunity of US$ 1.2 billion throughout the aforementioned forecast period, with a closing valuation of US$ 4.1 billion. The market for maleic anhydride expanded at a 4.0% CAGR between 2015 and 2021. The sector is…
Motion Control Market Anticipated to Achieve US$ 35.52 Billion Valuation by 2033
According to the most recent industry report by market research and competitive intelligence source Fact.MR, the global Motion Control Market is expected to reach US$ 35.52 billion by 2033, growing at a 5.1% CAGR from 2023 to 2033. the market is growing gradually due to a number of important variables. There is a strong desire for industrialization and automation in many different businesses. Businesses are searching for methods to boost…
Benzoic Acid Market: Approaching US$ 1.6 Billion by 2032 | Fact.MR
According to a recently released Fact.MR analysis, the Benzoic Acid Market is expected to generate revenues of US$ 1 billion in 2021 and rise at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2032. It is anticipated that the market will be valued US$ 1.6 billion by the end of 2032. the primary end-use application for benzoic acid is benzoates, whose use is increasing due to the…
Newborn Metabolic Screening Market to US$ 857.4 Million by 2034
According to estimates, the Newborn Metabolic Screening Market will be valued US$ 355.1 million by 2024. With a predicted growth rate of 9.2% between 2024 and 2034, the need for newborn metabolic screening is expected to rise in a positive manner. By 2034, the market is expected to be worth more than US$ 857.4 million. the market is growing mainly because parents and healthcare professionals are becoming more aware of…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
